RUTIGLIANO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.459
EU - Europa 549
AS - Asia 363
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 3.374
Nazione #
US - Stati Uniti d'America 2.447
CN - Cina 214
SE - Svezia 189
IT - Italia 146
SG - Singapore 108
DE - Germania 48
GB - Regno Unito 42
FI - Finlandia 37
UA - Ucraina 33
FR - Francia 18
BE - Belgio 17
VN - Vietnam 16
CA - Canada 12
IN - India 10
IR - Iran 6
RU - Federazione Russa 4
KR - Corea 3
CZ - Repubblica Ceca 2
IE - Irlanda 2
JP - Giappone 2
LT - Lituania 2
RO - Romania 2
AU - Australia 1
BD - Bangladesh 1
CO - Colombia 1
EG - Egitto 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MT - Malta 1
NL - Olanda 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
Totale 3.374
Città #
Fairfield 352
Chandler 259
Woodbridge 249
Ashburn 212
Seattle 170
Houston 168
Cambridge 145
Nyköping 144
Wilmington 127
Ann Arbor 122
Beijing 86
Singapore 84
Bari 82
Jacksonville 65
New York 53
Roxbury 42
Lawrence 40
Nanjing 29
Princeton 27
Des Moines 25
Inglewood 23
Dearborn 20
Boardman 17
Brussels 17
Dong Ket 16
Brooklyn 15
Shenyang 13
Los Angeles 12
San Diego 12
Nanchang 11
Tianjin 10
Hebei 9
Toronto 9
Changsha 8
Munich 8
Redwood City 7
Chicago 6
Helsinki 6
London 6
Pune 6
Hefei 5
Jiaxing 5
Noicattaro 5
Guangzhou 4
Kunming 4
Monmouth Junction 4
Rome 4
San Mateo 4
Augusta 3
Detroit 3
Falls Church 3
Frankfurt am Main 3
Gioia Del Colle 3
Leawood 3
Mola Di Bari 3
Ottawa 3
Paris 3
Seongnam-si 3
Ardabil 2
Barletta 2
Cardiff 2
Charlottesville 2
Chongqing 2
Dublin 2
Gioia del Colle 2
Grafing 2
Hounslow 2
Kilburn 2
Modugno 2
New Bedfont 2
Ningbo 2
Sabz 2
Sammichele Di Bari 2
Tappahannock 2
Washington 2
Wuhan 2
Alexandria 1
Amsterdam 1
Baotou 1
Belgrade 1
Birmingham 1
Bitonto 1
Brno 1
Budapest 1
Casamassima 1
Cisternino 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Danyang 1
Falkenstein 1
Fujita 1
Guiyang 1
Gunzenhausen 1
Haikou 1
Hunedoara 1
Iasi 1
Il-Madliena 1
Indianapolis 1
Jian 1
Jinan 1
Totale 2.837
Nome #
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 139
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 136
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 136
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 131
Isolation and characterization of cancer stem cells in renal cell carcinoma. 130
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 128
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 123
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 120
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 116
Rapamycin-Induced Hypophosphatemia and Insulin Resistance Are Associated With mTORC2 Activation and Klotho Expression 113
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 106
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 100
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 98
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 96
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 87
null 86
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 85
The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma 84
Cryopreserved Penile Tunica Albuginea for Allotransplantation: A Morphological and Ultrastructural Investigation. 82
Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles 82
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 81
Emerging urinary markers of renal injury in obstructive nephropathy. 77
null 74
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 73
The Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase 71
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 67
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 63
Analisi dei fattori critici nello studio MALDI-TOF del profilo peptidico urinario in soggetti sani e con cancro alla prostata 61
null 61
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 55
Regulation of TGF-beta 1 expression by Androgen Deprivation Therapy of prostate cancer 54
null 49
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 49
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 46
null 46
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 44
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 41
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 40
CTR2 Identifies a Population of Cancer Cells with Stem-Like Features in Patients with Clear Cell Renal Cell Carcinoma. 37
null 36
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 30
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 29
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 27
LOSS OF LKB1 EXPRESSION IS AN EARLY MOLECULAR EVENT IN PROSTATE CARCINOGENESIS 23
SP168 ARPCS CAN REVERT LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION OF ENDOTHELIAL CELLS 23
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 22
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer 22
null 16
To007 Adult Renal Stem/progenitor Cells Express Long Non-coding Rnas Involved In Wnt And The Bmp Signaling Pathway 16
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus 12
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 10
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 8
MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome 7
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma 4
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 1
The Role of MUC1 in Renal Cell Carcinoma. Biomolecules. 1
Totale 3.554
Categoria #
all - tutte 15.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020640 0 0 0 0 97 68 92 87 100 88 76 32
2020/2021552 27 63 25 39 74 18 48 52 33 64 69 40
2021/2022375 22 30 8 13 18 26 23 19 20 50 65 81
2022/2023619 96 106 48 63 48 86 4 65 68 6 16 13
2023/2024242 22 40 10 18 27 86 6 5 2 9 6 11
2024/2025203 30 22 69 59 23 0 0 0 0 0 0 0
Totale 3.554